Sarah Le Clair, PHARMD
Pharmacist · Santa Clara
- Medicare standing
- 1 flag on the record
- Listed below.
- Plans that list them
- Not verified
- Not the same as out of network.
- Office
- 1
On the public record
- Medicare does not list them as allowed to order and refer
Offices
1 location
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Sarah Le Clair’s office at (408) 851-1000 to ask if they take your plan before you enroll.
California Medical Board record
Licence G69092 · Cancelled
Licence status: Cancelled · since 1990 · University of Minnesota Medical School.
License has been voluntarily canceled, or the license has been expired for at least five years and has not been renewed. No practice is permitted.
Matched on the licence number without its letter prefix; check the name before relying on it.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Drugs they prescribed that Part D paid
$115,331
Pharmacies billed $115,331 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 721) in 2024. At or below the middle of the specialty; the typical pharmacist clinician is at 0%.
388 generic and 259 brand-name prescriptions · $115,331 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Ozempic | 50 | $37,697 | $754 |
| Jardiance | 23 | $12,767 | $555 |
| Humulin R | 44 | $9,057 | $206 |
| Humulin N | 53 | $8,369 | $158 |
| Humulin N Kwikpen | 13 | $3,221 | $248 |
See all 18 drugs
| Ozempic | 50 | $37,697 | $754 |
| Jardiance | 23 | $12,767 | $555 |
| Humulin R | 44 | $9,057 | $206 |
| Humulin N | 53 | $8,369 | $158 |
| Humulin N Kwikpen | 13 | $3,221 | $248 |
| Insulin Glargine-Yfgn | 24 | $3,201 | $133 |
| Humalog | 14 | $2,550 | $182 |
| Metformin | 100 | $1,217 | $12 |
| Atorvastatin | 89 | $1,039 | $12 |
| Glipizide | 67 | $841 | $13 |
| Veo Insulin | 15 | $638 | $43 |
| Ultra-Fine Nano Pen Needle | 23 | $564 | $25 |
| Metformin Hcl Er | 41 | $409 | $10 |
| Veo Insulin | 14 | $373 | $27 |
| Glipizide Er | 11 | $310 | $28 |
| Lisinopril | 17 | $228 | $13 |
| Simvastatin | 16 | $187 | $12 |
| Pioglitazone | 16 | $187 | $12 |
Year by year
| 2024 | 721 | 119 | 0% (0) | 36% | $115,331 |
| 2023 | 632 | 113 | 0% (0) | 32% | $86,577 |
| 2022 | 518 | 115 | 0% (0) | 36% | $69,080 |
| 2021 | 366 | 112 | 0% (0) | 39% | $38,984 |
| 2020 | 455 | 111 | 0% (0) | 37% | $51,014 |
| 2019 | 321 | 80 | 0% (0) | 35% | $33,702 |
| 2018 | 359 | 82 | 0% (0) | 41% | $57,450 |
| 2017 | 361 | 83 | 0% (0) | 48% | $125,101 |
| 2016 | 144 | 57 | 0% (0) | 50% | $170,416 |
| 2015 | 46 | 26 | 0% (0) | None | $24,559 |
| 2014 | 40 | 28 | 0% (0) | 40% | $5,245 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 18 drugs
| Jardiance | 19 | $16,887 | $889 |
| Humulin N | 65 | $12,518 | $193 |
| Humulin R | 42 | $7,822 | $186 |
| Humulin N Kwikpen | 22 | $5,175 | $235 |
| Humalog | 13 | $5,145 | $396 |
| Humulin 70-30 | 12 | $2,785 | $232 |
| Metformin | 89 | $1,693 | $19 |
| Atorvastatin | 83 | $1,041 | $13 |
| Glipizide | 62 | $753 | $12 |
| Ultra-Fine Nano Pen Needle | 28 | $620 | $22 |
| Metformin Hcl Er | 47 | $455 | $10 |
| Veo Insulin | 11 | $448 | $41 |
| Pioglitazone | 13 | $332 | $26 |
| Veo Insulin | 15 | $318 | $21 |
| Glimepiride | 13 | $172 | $13 |
| Lisinopril | 13 | $165 | $13 |
| Simvastatin | 13 | $152 | $12 |
| Losartan | 11 | $128 | $12 |
2022: 13 drugs
| Humulin N | 57 | $8,617 | $151 |
| Humulin R | 37 | $6,375 | $172 |
| Humulin N Kwikpen | 22 | $5,924 | $269 |
| Humalog | 15 | $5,708 | $381 |
| Humalog Kwikpen U-100 | 11 | $3,365 | $306 |
| Atorvastatin | 65 | $838 | $13 |
| Glipizide | 63 | $733 | $12 |
| Metformin | 51 | $631 | $12 |
| Veo Insulin | 22 | $527 | $24 |
| Veo Insulin | 12 | $464 | $39 |
| Metformin Hcl Er | 36 | $375 | $10 |
| Ultra-Fine Nano Pen Needle | 13 | $232 | $18 |
| Simvastatin | 12 | $140 | $12 |
2021: 9 drugs
| Humulin N | 58 | $9,055 | $156 |
| Humulin R | 42 | $6,936 | $165 |
| Metformin | 47 | $578 | $12 |
| Glipizide | 45 | $545 | $12 |
| Veo Insulin | 19 | $454 | $24 |
| Atorvastatin | 30 | $355 | $12 |
| Veo Insulin | 13 | $353 | $27 |
| Metformin Hcl Er | 22 | $240 | $11 |
| Veo Insulin | 12 | $223 | $19 |
2020: 11 drugs
| Humulin N | 58 | $10,353 | $179 |
| Humulin R | 58 | $9,946 | $171 |
| Humulin 70-30 | 17 | $4,688 | $276 |
| Humulin N Kwikpen | 11 | $3,379 | $307 |
| Glipizide | 57 | $745 | $13 |
| Atorvastatin | 53 | $738 | $14 |
| Metformin | 57 | $664 | $12 |
| Veo Insulin | 30 | $625 | $21 |
| Glimepiride | 15 | $182 | $12 |
| Veo Insulin | 12 | $161 | $13 |
| Metformin Hcl Er | 14 | $128 | $9 |
2019: 10 drugs
| Humulin N | 39 | $8,370 | $215 |
| Humulin R | 35 | $6,254 | $179 |
| Humulin 70-30 | 16 | $4,072 | $255 |
| Glipizide | 54 | $743 | $14 |
| Atorvastatin | 25 | $607 | $24 |
| Veo Insulin | 27 | $508 | $19 |
| Metformin | 35 | $425 | $12 |
| Veo Insulin | 14 | $413 | $29 |
| Metformin Hcl Er | 13 | $132 | $10 |
| Simvastatin | 11 | $128 | $12 |
2018: 11 drugs
| Humulin N | 49 | $10,574 | $216 |
| Humulin R | 37 | $6,407 | $173 |
| Humulin 70-30 | 17 | $3,615 | $213 |
| Glipizide | 67 | $983 | $15 |
| Veo Insulin | 28 | $735 | $26 |
| Atorvastatin | 22 | $518 | $24 |
| Veo Insulin | 13 | $341 | $26 |
| Metformin | 27 | $331 | $12 |
| Metformin Hcl Er | 24 | $322 | $13 |
| Ultra-Fine Mini Pen Needle | 11 | $316 | $29 |
| Simvastatin | 13 | $146 | $11 |
2017: 10 drugs
| Humulin N | 60 | $10,581 | $176 |
| Humulin 70-30 | 28 | $5,763 | $206 |
| Humulin R | 38 | $4,888 | $129 |
| Glipizide | 62 | $928 | $15 |
| Insulin | 29 | $652 | $22 |
| Atorvastatin | 23 | $555 | $24 |
| Metformin Hcl Er | 21 | $321 | $15 |
| Insulin | 11 | $308 | $28 |
| Metformin | 22 | $268 | $12 |
| Lisinopril | 11 | $128 | $12 |
2016: 5 drugs
| Humulin N | 22 | $3,567 | $162 |
| Humulin 70-30 | 14 | $2,608 | $186 |
| Glipizide | 16 | $280 | $17 |
| Warfarin | 16 | $246 | $15 |
| Insulin | 12 | $228 | $19 |
2015: 1 drug
| Warfarin | 36 | $559 | $16 |
2014: 2 drugs
| Lovenox | 16 | $4,441 | $278 |
| Warfarin | 23 | $386 | $17 |
Professional record
- NPI
- 1790114734
- Licence
- CA 69092California G69092: Cancelled
More record details
- Sole proprietor
- Yes
- Taxonomy
- Federal specialty code 183500000X (183500000X)
- Mailing address
- 700 Lawrence Expy, Santa Clara, CA, 95051
- NPI first listed
- 2013-11-08
- NPI last updated
- 2013-11-08
This is when the NPI record was last certified, not a medical board exam.